Redcliffe Labs Revenue and Competitors

Noida, India

Location

N/A

Total Funding

Fitness

Industry

Employee Data

  • Redcliffe Labs has 1189 Employees.(i)
  • Redcliffe Labs grew their employee count by 8% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
N/A24328%N/AN/A
#2
$1.7M100769%N/AN/A
#3
N/A175-16%N/AN/A
#4
$3.5M77261%N/AN/A
#5
N/A11898%N/AN/A
#6
N/A1355%N/AN/A
#7
N/A2878%N/AN/A
#8
N/A10638%N/AN/A
#9
N/A6362%N/AN/A
Add Company

Redcliffe Labs (unit of US-based Redcliffe Lifetech Inc) is India's fastest growing diagnostics service provider having its home sample collection service in more than 60 cities with 20+ labs across India. It aims to make Health tests accessible to all Indians through a perfect fusion of technology and a network of world-class & state of the art own labs and collection centres. Redcliffe Labs provides diagnostics with a comprehensive portfolio approach both with routine and specialized test menu & advanced testing labs all over India. Its digital-first approach with on-demand 1 hour home collection and same-day reports is disrupting the way diagnostics is delivered today.

keywords:N/A

N/A

Total Funding

1189

Number of Employees

N/A

Revenue (est)

8%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Redcliffe Labs News

2022-04-20 - Redcliffe Labs is amplifying business with digital tools

Redcliffe Labs is leveraging AI-ML tools to reverse the impact of diseases organically. AI and ML tools are used to compare the diseases with a...

2022-04-13 - Redcliffe Labs appoints Prof SS Anand as medical director

Anand will drive the nationwide expansion and growth plan for Redcliffe Imaging. Redcliffe Labs has appointed Prof SS Anand as the new...

2022-03-22 - Redcliffe Labs partners with Royal Challengers Bangalore

Redcliffe Labs is fast carving a niche for itself by offering good quality healthcare and being India's fastest growing diagnostics service...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$138.9M136831%N/A
#2
$251.9M138425%N/A
#3
$198M140719%N/A
#4
$308.6M1520N/AN/A
#5
$686.7M152811%N/A